The potential function of microRNA in chordomas

Sukru Gulluoglu1, Emre Can Tuysuz2, Aysegul Kuskucu3

  • 1Department of Medical Genetics, Yeditepe University Medical School, Inonu Mah Kayisdagi Cad. 26 Agustos Yerlesimi, 34755 Atasehir, Istanbul, Turkey; Department of Biotechnology, Institute of Science Yeditepe University, Inonu Mah. Kayisdagi Cad. 26 Agustos Yerlesimi, 34755 Atasehir, Istanbul, Turkey.

Gene
|March 27, 2016
PubMed

Insights

This study investigated microRNAs (miRNAs) in chordoma, a rare cancer. Specific miRNAs like miR-31 were found to impact cell viability, apoptosis, and cell cycle, offering potential therapeutic targets for chordoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Chordomas are rare, chemoresistant tumors lacking established treatments.
  • MicroRNAs (miRNAs) are crucial regulators of gene networks and cellular pathways.
  • Understanding miRNA dysregulation in chordomas is key to elucidating tumor initiation and progression.

Purpose of the Study:

  • To evaluate the effects of dysregulated miRNAs on chordoma cell lines.
  • To identify potential molecular mechanisms underlying chordoma development.
  • To explore novel therapeutic targets for chordoma.

Main Methods:

  • Transient transfection of specific miRNA mimics (miR-31, anti-miR-140-3p, anti-miR148a, miR-222) into chordoma cell lines.
  • Assessment of cell viability (MTS assay), apoptosis, and cell cycle progression.
  • Real-time polymerase chain reaction to analyze mRNA levels of miRNA targets and epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) markers.

Main Results:

  • miR-31 significantly decreased cell viability and induced S-phase arrest in chordoma cell lines.
  • Both miR-31 and anti-miR-148a promoted apoptosis across all tested cell lines.
  • miR-222 levels correlated positively with EMT markers and negatively with MET markers.
  • Identified targets include RDX, MET, DNMT1, DNMT3B, TRPS1, BIRC5, and KIT.

Conclusions:

  • miR-31, miR-140-3p, miR-148a, and miR-222-3p show potential as key regulators of chordoma cell viability, apoptosis, and cell cycle.
  • These miRNAs may play significant roles in chordoma initiation, differentiation, and progression.
  • Further investigation into these miRNAs could lead to novel therapeutic strategies for chordoma.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

12.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K